|
Market Cap (2-Jul) $10,319,610 (791st) |
Close (30-Jun) $0.022 |
Volume (30-Jun) 1,033,118 |
Shortsold (7-Aug) 1,552,633 (0.26%) (384th) |
|
52w High $0.028 |
52w Low $0.014 |
P/E 54.95 |
EPS -0.01 |
AT1 released this announcement to the ASX on 18 January 2023, 9:28. The announcement is marked as price sensitive, and is 3 page(s) in length and 192.04kb in size.
You can view all announcements from AT1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AT1 was 0.019% short sold according to ASIC data. It was ranked the 573rd most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.256% of total shares short sold as of the latest reported data (07 August 2023).
| Other Recent Announcements from AT1 | |
|---|---|
| Ceasing to be a substantial holder | 23 June 2023, 16:26 |
| Exclusive Agreement for HIV Testing Signed with Newfoundland | 14 June 2023, 9:54 |
| Change in substantial holding | 6 June 2023, 18:02 |
| Agreement for Rapid Pregnancy Tests Signed with NG Biotech | 18 January 2023, 9:28 |
| Initial Director's Interest Notice - Dr Walker | 15 November 2022, 8:57 |
| Appointment of Independent Non-Executive Director | 15 November 2022, 8:53 |
| Investor Webinar and Presentation | 28 October 2022, 9:16 |
You must be logged in to post a reply.
